Videos

What can we help you find?
constipation
Expert panelists conclude their discussion with parting advice on the management of opioid-induced constipation.
Key opinion leaders discuss the importance of HRD testing, with special consideration of tissue testing versus somatic testing.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Utilizing a DOAC
Considerations for transitioning patients from heparin over to a direct oral anticoagulant for venous thromboembolism prophylaxis, and strategies that can help health care professionals better manage patients through a drug shortage.
revenue integrity
Girish Dighe, PharmD, MS, explains why it's important to understand more than just the revenue integrity piece of the puzzle. 
Unmet Needs
Turning toward the future management of opioid-induced constipation, the panel defined unmet needs and potential evolutions in care.
Ovarian Cancer 6
A discussion on how to bring awareness to clinicians that are not aware of the role of an oncology pharmacist. 
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Immunologically Silent Tumors in Breast Cancer
Rita Nanda, MD, explains how researchers are aiming to make immunologically silent tumors more inflamed. This video was filmed at the 2019 San Antonio Breast Cancer Symposium.
Potassium Binders
Jaclyn Harth, PharmD, clinical assistant professor, Fairleigh Dickinson School of Pharmacy, discusses 1 of the clinical pearls for potassium binders. This video was filmed at the ASHP (American Society of Health-System Pharmacists) 54th Clinical Meeting & Exhibition in Las Vegas, Nevada.
Banu Arun, MD, explains the potential risks of passive genetic counseling via videos or at-home tests. This video was filmed December 12 at the 2019 San Antonio Breast Cancer Symposium.
Treating With a DOAC for VTE Prophylaxis
Implications for treating appropriate patients with a direct oral anticoagulant, such as rivaroxaban, based on more recent trial data and a new indication for the prevention of venous thromboembolism.